BI 443651 Methacholine Challenge

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary objective of this study is to investigate safety and tolerability of three consecutive administrations, 12 hours apart, at three different dose-levels of BI 443651 administered via oral inhalation in male and female mild asthmatic subjects after a bolus methacholine challenge.
Epistemonikos ID: cca47487833689008d7c29eb7a4657813bbec1a9
First added on: May 20, 2024